Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dyax
Dyax issued sixth U.S. patent in its phage display patent portfolio
November 7th, 2006
Dyax Corp. (DYAX) announced that the United States Patent and Trademark office issued U.S. Patent No. 7,118,879, Dyax's sixth U.S. patent covering its proprietary phage display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting antibodies physically associated with filamentous phage. In addition to its six U.S. patents, Dyax holds several issued patents for phage display in Canada, Israel, and Japan, with pending applications in other countries. "The announcement of this newly issued patent further strengthens our phage display patent portfolio, which has been licensed non-exclusively to an...
Source: Drug Law Weekly (2006-11-07)
|
